Health News

What You Eat and Drink Affects Your MS
If you have multiple sclerosis, will drinking wine make the disease worse? How about smoking? Or eating fish? How do daily choices affect your condition?
Ocrelizumab Maintained Significant Reduction in Muliple Sclerosis
Roche announced 96-week results from a Phase II study of ocrelizumab in patients with relapsing-remitting multiple sclerosis (RRMS), the most common clinical form of the disease. Phase III trials underway to investigate ocrelizumab in two forms of MS.
Memory Tricks for MS Patients
Have you ever gone to the grocery store and forgotten an item you went there to get? A technique used to improve learning and memory in multiple sclerosis patients may help you, too.
Long-Term Benefits With MS Drug
Primary progressive multiple sclerosis (PPMS) has no established course of treatment. But follow up results from a drug trial provide a glimmer of hope for patients.
Multiple Sclerosis and Depression Mixture
Dealing with a debilitating disease is challenging on its own. Add depression on top of it, and the burden of disease is crippling. For many patients with MS, that's reality.
A New Treatment for MS?
A new drug for multiple sclerosis (MS) has shown promising results in clinical trials. The drug, called ocrelizumab, has a novel new target to treat the disease.
Breath Test for Multiple Sclerosis
Imagine being able to detect a life-changing disease with just an exhale. That's how doctors plan to diagnose multiple sclerosis.
Walking With MS May be a Challenge
It's common for people with multiple sclerosis (MS) to have trouble walking or maintaining balance. For most MS sufferers, this is the most difficult aspect of living with the disease.
Balancing Vitamin D and Multiple Sclerosis
Scientists believe that maintaining sufficient levels of vitamin D can lower the risk of developing multiple sclerosis (MS). But can high doses help people who already have the disease?
Stem cell techniques for MS
A cutting-edge stem cell therapy for treating multiple sclerosis (MS) is one step closer to reality. New research targets myelin, a material that coats neurons in the brain.